Capital Signal

Cynata Therapeutics Limited (ASX: CYP)

Sector: Health Care

Market cap: A$3M (as of 2 Nov 2026)

Clinical stage biotechnology company specialising in cell therapeutics

Data as of 2 Nov 2026.

Recent capital raises

DateTypeAmountPriceDiscountSource
30 Oct 2026Rights issue$0.235M$0.01—Filing ↗
8 Oct 2026Rights issue$0.913M$0.019.1% discountFiling ↗
4 May 2026Placement$1.5M$0.2522.5% discountFiling ↗
6 Dec 2024Placement$8.1M$0.1816.3% discountFiling ↗
10 May 2023SPP$2.05M$0.152.5% discountFiling ↗

Substantial holders — latest moves

DateHolderMoveHoldingSource
2 July 2026FIL Limited and its entities listed in Annexure AExit—Filing ↗
2 July 2026FIL LimitedDecrease8.83% → 6.38%Filing ↗
29 June 2026Hugh PilgrimEntry?% → 6.860%Filing ↗
23 June 2026Phillip Asset Management Ltd atf Bioscience Managers Translation Fund 1Exit—Filing ↗
10 Oct 2025Phillip Asset Management Ltd atf BioScience Managers Translation Fund IEntry?% → 9.93%Filing ↗

Director trades — on-market

DateDirectorTradeSource
21 Nov 2023Dr Kilian KellyBought 94,143Filing ↗
30 Nov 2021Mr Geoffrey Edward Duncan BrookeBought 40,809Filing ↗
30 Nov 2021Dr Stewart James WasherBought 60,000Filing ↗
24 June 2020Mr Geoffrey Edward Duncan BrookeBought 77,000Filing ↗

Cash and runway

MetricValueAs ofSource
CashA$175K30 Sept 2026Filing ↗
Runway0.1 quarters30 Sept 2026Filing ↗

Ask about CYP in Claude or ChatGPT

Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:

  • Has CYP raised money in the last year, and at what discount?
  • What was CYP's latest cash position and runway?

Setup guide for Claude, ChatGPT and other MCP clients →

Loading CYP…

Cynata Therapeutics Limited (ASX: CYP): capital raises, holders, director trades | Capital Signal